Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

I tried anti-obesity medication and these were the surprising side-effects' - When Henry Conway hit his forties his BMI became dangerously high. After a lover said ‘I love your little dad bod’, he ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s. Congress is also considering such a move.

Opens in a new tab or window In July 2024, Joseph Zucchi, PA-C, MPAS, wrote about how stigma and misconceptions were creating barriers to GLP-1 obesity medication uptake, on top of systemic ...

About 25% of Americans have a health insurance plan that covers these weight loss drugs, according to the AXIACI Obesity Coverage Nexus, a database produced by the Leverage consulting firm.

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications. More than an estimated million Floridians are now using weight-loss medications, and experts ...

Medicare, by statute, is still prohibited from paying for the use of obesity medications — a policy that is discriminatory and a reflection of the stigmatization of obesity. The popular focus on ...

In a world grappling with obesity and chronic disease, GLP-1 drugs like Ozempic are emerging as transformative game-changers.